Equities

Arcticzymes Technologies ASA

Arcticzymes Technologies ASA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NOK)17.34
  • Today's Change-1.36 / -7.27%
  • Shares traded1.22m
  • 1 Year change-45.39%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of NOK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments181244200
Total Receivables, Net141426
Total Inventory137.086.88
Prepaid expenses2.003.94--
Other current assets, total700.00--
Total current assets280269233
Property, plant & equipment, net272928
Goodwill, net------
Intangibles, net269.241.79
Long term investments------
Note receivable - long term------
Other long term assets--0.000.00
Total assets339319284
LIABILITIES
Accounts payable4.545.595.80
Accrued expenses7.92----
Notes payable/short-term debt000
Current portion long-term debt/capital leases4.173.733.10
Other current liabilities, total4.981516
Total current liabilities222425
Total long term debt8.411014
Total debt131418
Deferred income tax------
Minority interest------
Other liabilities, total0.00----
Total liabilities303439
SHAREHOLDERS EQUITY
Common stock515150
Additional paid-in capital264262260
Retained earnings (accumulated deficit)(5.52)(27)(66)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total----0.00
Total equity309285245
Total liabilities & shareholders' equity339319284
Total common shares outstanding515150
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.